Keyphrases
4T1 Breast Cancer Cells
8%
AR Antagonism
8%
AR Inhibitors
8%
Astrocytes
50%
Brain Metastases
33%
Breast Cancer Brain Metastasis
50%
Breast Tumor
50%
Cancer Cell Interactions
16%
Cancer Progression
16%
Cell Lysate
8%
Combination Therapy
50%
Complex Interplay
8%
CXCL10
33%
Cytokine IL-6
8%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Glucocorticoid Receptor
75%
Glucocorticoid Receptor Antagonism
100%
Glucocorticoid Receptor beta
50%
Hormone Exposure
8%
Hormone Receptor
16%
Hormone Treatment
8%
IL-6 Expression
8%
Immune Cells
50%
In Cancer
8%
Inhibitor Treatment
8%
Interleukin-6
16%
Metastasis
50%
Modulatory Effects
8%
Negative Breast Cancer
8%
Receptor Activation
50%
Receptor Antagonism
8%
Receptors Adrenergic
8%
Standard of Care
50%
Statistical Significance
8%
Stress Hormones
50%
Therapeutic Target
8%
TNF-α Expression
8%
Triple-negative Breast Cancer
50%
Tumor Biology
50%
Tumor Microenvironment
50%
Tumor Necrosis Factor-α
16%
University of Brighton
50%
Western Blotting
8%
β-adrenergic Receptor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Adrenergic Receptor
50%
Brain Metastasis
50%
Breast Cancer
41%
Cancer Growth
16%
Combination Therapy
25%
Cytokine
8%
Enzyme-Linked Immunosorbent Assay
16%
Glucocorticoid Receptor
100%
Hormone Receptor
16%
Interleukin 6
33%
Malignant Neoplasm
16%
Neoplasm
25%
Receptor
8%
Stress Hormone
50%
Triple Negative Breast Cancer
50%
Tumor Microenvironment
25%
Tumor Necrosis Factor
25%
Western Blot
8%
Medicine and Dentistry
Breast Cancer
25%
Combination Therapy
25%
Doctor of Philosophy
25%
Glucocorticoid Receptor
50%
Immunocompetent Cell
25%
Metastatic Carcinoma
25%
Tumor Biology
25%
Tumor Microenvironment
25%
